As of Aug 26
| -0.20 / -4.30%|
The 1 analysts offering 12-month price forecasts for Cumberland Pharmaceuticals Inc have a median target of 5.50, with a high estimate of 5.50 and a low estimate of 5.50. The median estimate represents a +23.60% increase from the last price of 4.45.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.